krystal biotech shares were up 13 to 10809 after the company said it has entered into a securities purchase agreement for the sale of 17 million shares at 9250 a share in a private placement to certain qualified institutional buyers the stock closed fridays session up 10 and is up 84 in the past 12 months proceeds from the placement are expected to be 160 million before deducting any offeringrelated expenses the transaction is expected to close monday subject to the satisfaction of customary closing conditions